Advertisement
Research ArticleArticle

Drug-Metabolizing Enzyme Inhibition by Ketoconazole Does Not Reduce Interindividual Variability of CYP3A Activity as Measured by Oral Midazolam

Maylee Chen, Anne N. Nafziger and Joseph S. Bertino Jr.
Drug Metabolism and Disposition December 2006, 34 (12) 2079-2082; DOI: https://doi.org/10.1124/dmd.106.011742
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

Drug-Metabolizing Enzyme Inhibition by Ketoconazole Does Not Reduce Interindividual Variability of CYP3A Activity as Measured by Oral Midazolam

Maylee Chen, Anne N. Nafziger and Joseph S. Bertino
Drug Metabolism and Disposition December 1, 2006, 34 (12) 2079-2082; DOI: https://doi.org/10.1124/dmd.106.011742
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement